Lipella Pharmaceuticals Inc
Lipella Pharmaceuticals Inc is a biotechnology company based in Pittsburgh, PA, specializing in supportive care for cancer survivors with hemorrhagic cystitis, also known as radiation cystitis, and improved surveillance and imaging for patients with a history of transitional cell carcinoma. They also focus on the treatment of oral lichen planus using their proprietary drug delivery system to the oral mucosa.
With a sterile manufacturing facility in Pittsburgh, PA, Lipella Pharmaceuticals Inc produces clinical supplies and research products. They have recently completed a phase 2A multi-center dose-escalation clinical trial for their lead product, LP-10, and have submitted their pipeline asset, LP-310, for initial IND review by the FDA. Lipella Pharmaceuticals Inc aims to address highly-morbid indications where no adequate treatments currently exist through the development of proprietary assets.
Generated from the website
Also at this address
You might also like
Partial Data by Infogroup (c) 2025. All rights reserved.
